Quantification of isotopic niche overlap in fjords. by Nathan D. McTigue (10706460)

Subjects:

Posterior estimates of niche overlap for predators. by Nathan D. McTigue (10706460)

Subjects:

Posterior estimates of niche overlap for deposit feeders. by Nathan D. McTigue (10706460)

Subjects:

Posterior estimates of niche overlap for suspension feeders. by Nathan D. McTigue (10706460)

Subjects:

Histogram of day-of-year for sample collection for data collected for this meta-analysis. by Nathan D. McTigue (10706460)

Subjects:

Posterior estimates of niche overlap for opportunist/scavengers. by Nathan D. McTigue (10706460)

Subjects:

Stable isotope biplots of end-members (colored points) faceted by coastscape and overlayed consumers (gray points). by Nathan D. McTigue (10706460)

Subjects:

Data Sheet 1_Associations of NETs with inflammatory risk and clinical predictive value in large artery atherosclerosis stroke: a prospective cohort study.docx by Jiang Li (272926)

“…</p>Results<p>The serum MPO-DNA, PAD4, C1q, IL-1β, IL-6 and IL-8 reach their peak at 24 hours after stroke onset and show a decreasing trend during acute phase. …”

<i>E</i> values weakly decrease with absolute latitude. by Dimitrios—Georgios Kontopoulos (9530566)

Data Sheet 2_Large scale deletion and rebalancing within the k1C kafirin family in sorghum.pdf by Tyler W. Ferris (22481194)

“…Despite confirming a ~400-kb deletion in the k1C family of both edited lines encompassing seven active genes, no significant decrease was observed in k1C expression or compensatory increase in non-kafirin proteins. …”

Extreme morphological adaptations to accommodate large teeth in fish jaws. by Nick Peoples (21593888)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Decreased recovery times were observed after repeated handling and anesthesia sessions. by Lingzhi Wang (114519)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Mitochondrial depolarization in <i>C</i>. <i>auris</i>. by Hammad Alam (530008)

Subjects:

Sustainable Collagen Blends with Different Ionic Liquids for Resistive Touch Sensing Applications by Mireia Andonegi (14855252)

“…Considering the sustainable development goals to reduce environmental impact, sustainable sensors based on natural polymers are a priority as the large im plementation of these materials is required considering the Internet of Things (IoT) paradigm. …”

TGA/DTG curves of biomass <i>S</i>. <i>platensis</i> degradation grown under different culture medium (a) A (b) M2.5 (c) M5 (d) M10. by Sueilha F. A. Paula (13988800)

Subjects:

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)